Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Andreone

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
Nature Medicine|February 16, 2023
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trialArun J Sanyal, Patricia Lopez, Eric J Lawitz, et al.
The New England Journal of Medicine|November 8, 2022
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B InfectionMan-Fung Yuen, Seng-Gee Lim, Robert Plesniak, et al.
Expert Review of Anti-Infective Therapy|December 25, 2018
Real life experiences in HCV management in 2018Mauro Viganò, Massimo Andreoni, Carlo Federico Perno, et al.
Hepatology (Baltimore, Md.)|December 17, 2021
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohortLoreta A Kondili, Monica Monti, Maria Giovanna Quaranta, et al.
The New England Journal of Medicine|August 18, 2016
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Pietro Andreone, Giuseppe Mazzella, et al.
Gastroenterology|April 2, 2019
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic HepatitisCarolina Boni, Harry L A Janssen, Marzia Rossi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2026
Unmet needs in hepatology: The guidance of the Italian association for the study of the liver (AISF)Stefano Gitto, Filippo Gabrielli, Giovanni Addolorato, et al.
The New England Journal of Medicine|November 14, 2023
Efficacy and Safety of Elafibranor in Primary Biliary CholangitisKris V Kowdley, Christopher L Bowlus, Cynthia Levy, et al.
Journal of Hepatology|May 17, 2019
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysisFanpu Ji, Yee Hui Yeo, Mike Tzuhen Wei, et al.
Journal of Hepatology|August 30, 2024
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis BMaria Buti, Jeong Heo, Yasuhito Tanaka, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Nature Medicine|February 16, 2023
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trialArun J Sanyal, Patricia Lopez, Eric J Lawitz, et al.
The New England Journal of Medicine|November 8, 2022
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B InfectionMan-Fung Yuen, Seng-Gee Lim, Robert Plesniak, et al.
Expert Review of Anti-Infective Therapy|December 25, 2018
Real life experiences in HCV management in 2018Mauro Viganò, Massimo Andreoni, Carlo Federico Perno, et al.
Hepatology (Baltimore, Md.)|December 17, 2021
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohortLoreta A Kondili, Monica Monti, Maria Giovanna Quaranta, et al.
The New England Journal of Medicine|August 18, 2016
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Pietro Andreone, Giuseppe Mazzella, et al.
Gastroenterology|April 2, 2019
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic HepatitisCarolina Boni, Harry L A Janssen, Marzia Rossi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2026
Unmet needs in hepatology: The guidance of the Italian association for the study of the liver (AISF)Stefano Gitto, Filippo Gabrielli, Giovanni Addolorato, et al.
The New England Journal of Medicine|November 14, 2023
Efficacy and Safety of Elafibranor in Primary Biliary CholangitisKris V Kowdley, Christopher L Bowlus, Cynthia Levy, et al.
Journal of Hepatology|May 17, 2019
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysisFanpu Ji, Yee Hui Yeo, Mike Tzuhen Wei, et al.
Journal of Hepatology|August 30, 2024
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis BMaria Buti, Jeong Heo, Yasuhito Tanaka, et al.
Pageof 19